BRAF and melanoma: The suppression of PDH and relevant mitochondrial function is capable of abrogating BRAF-induced senescence, thereby licensing BRAF-driven melanoma development.211 Therefore, mitochondrial function switches from tumor suppressor to oncogenic factor during melanoma carcinogenesis and development.